Andreas Clemens
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, Cardiac Arrhythmias and Treatments, Chronic Obstructive Pulmonary Disease (COPD) Research, Retinal Diseases and Treatments
Most-Cited Works
- → Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity(2010)1,372 cited
- → Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients(2011)354 cited
- → Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor(2009)332 cited
- → Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control(2008)295 cited
- → Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference(2011)239 cited
- → The Artificial Beta Cell - A Continuous Control of Blood Sugar by External Regulation of Insulin Infusion (Glucose Controlled Insulin Infusion System)(1974)233 cited